PlexusDx compounds and ships fresh medication each month, ensuring your treatment maintains full clinical potency
NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024
Attempting to have adequate nutrition on a calorie-reduced diet with digestive support and muscle mass maintenance
This is not medical advice and does not substitute advice from your health care provider.Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
They are not a shortcut to significant weight loss on their own
Suggested Research Combinations P21 a CNTF-derived neurogenic compound acting through BDNF, the parallel-pathway comparator